WCBA
CVS icon

Weaver C. Barksdale & Associates’s CVS Health CVS Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17,007
Closed -$1.07M – 63
2024
Q3 		$1.07M Sell
17,007
-627
-4% -$36.6K 0.96% 55
2024
Q2 		$1.04M Sell
17,634
-250
-1% -$15.6K 0.99% 56
2024
Q1 		$1.42M Sell
17,884
-126
-0.7% -$9.63K 1.31% 46
2023
Q4 		$1.42M Sell
18,010
-4,512
-20% -$321K 1.39% 41
2023
Q3 		$1.57M Buy
22,522
+3,755
+20% +$266K 1.34% 46
2023
Q2 		$1.3M Sell
18,767
-1,132
-6% -$80.5K 1.28% 50
2023
Q1 		$1.48M Sell
19,899
-944
-5% -$79.2K 1.38% 47
2022
Q4 		$1.94M Buy
20,843
+533
+3% +$51.4K 1.71% 28
2022
Q3 		$1.94M Sell
20,310
-702
-3% -$69.5K 1.94% 9
2022
Q2 		$1.95M Buy
21,012
+1,391
+7% +$136K 1.81% 17
2022
Q1 		$1.99M Sell
19,621
-2,877
-13% -$302K 1.77% 21
2021
Q4 		$2.32M Buy
+22,498
New +$2.08M 2.1% 5
2017
Q4 		$1.51M Buy
20,860
+2,438
+13% +$177K 1.59% 29
2017
Q3 		$1.5M Buy
18,422
+915
+5% +$72.4K 1.67% 23
2017
Q2 		$1.41M Hold
17,507
– – 1.64% 24
2017
Q1 		$1.37M Buy
17,507
+4,700
+37% +$375K 1.62% 30
2016
Q4 		$1.01M Buy
+12,807
New +$1.04M 1.63% 13

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Weaver C. Barksdale & Associates's CVS Position: Q4 2024 in Review

Weaver C. Barksdale & Associates sold out of CVS Health (CVS) in Q4 2024, closing a stake of 17,007 shares — an estimated $1.07M sold.

Weaver C. Barksdale & Associates first reported a position in CVS in Q4 2016 and held it in 17 quarters. The position peaked at $2.32M in Q4 2021. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Weaver C. Barksdale & Associates reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Weaver C. Barksdale & Associates sold 17,007 CVS Health shares in Q4 2024, an estimated $1.07M.
  • Weaver C. Barksdale & Associates first reported a position in CVS Health in Q4 2016 and held it in 17 quarters.
  • Weaver C. Barksdale & Associates's CVS Health position peaked at $2.32M in Q4 2021.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2024, filed 12 Feb 2025.